The company is in the first inning with its HIFU treatment of prostate cancer, enjoying near triple-rate growth in Q2. Its other business is more steady, but also had a good quarter. Given the growth, the large margin expansion and profitability, and the additional HIFU treatment opportunities further away in time we think the shares […]
Entries Tagged as 'EDAP'
October 7th, 2019 · No Comments